These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38723679)

  • 1. Cerebrospinal fluid synaptic biomarker changes in bipolar disorder - A longitudinal case-control study.
    Knorr U; Simonsen AH; Nilsson J; Brinkmalm A; Zetterberg H; Blennow K; Knudsen MB; Forman J; Hasselbalch SG; Kessing LV
    J Affect Disord; 2024 Aug; 358():250-259. PubMed ID: 38723679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia.
    Sogorb-Esteve A; Nilsson J; Swift IJ; Heller C; Bocchetta M; Russell LL; Peakman G; Convery RS; van Swieten JC; Seelaar H; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Tartaglia MC; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; Santana I; Butler CR; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Sorbi S; Le Ber I; Pasquier F; Gobom J; Brinkmalm A; Blennow K; Zetterberg H; Rohrer JD;
    Alzheimers Res Ther; 2022 Aug; 14(1):118. PubMed ID: 36045450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease related biomarkers in bipolar disorder - A longitudinal one-year case-control study.
    Knorr U; Simonsen AH; Jensen CS; Zetterberg H; Blennow K; Akhøj M; Forman J; Hasselbalch SG; Kessing LV
    J Affect Disord; 2022 Jan; 297():623-633. PubMed ID: 34728295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study.
    Knorr U; Simonsen AH; Roos P; Weimann A; Henriksen T; Christensen EM; Vinberg M; Mikkelsen RL; Kirkegaard T; Jensen RN; Akhøj M; Forman J; Poulsen HE; Hasselbalch SG; Kessing LV
    Transl Psychiatry; 2019 Nov; 9(1):325. PubMed ID: 31780642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for neurodegeneration impact cognitive function: a longitudinal 1-year case-control study of patients with bipolar disorder and healthy control individuals.
    Knorr U; Simonsen AH; Zetterberg H; Blennow K; Willkan M; Forman J; Miskowiak K; Hasselbalch SG; Kessing LV
    Int J Bipolar Disord; 2024 Jan; 12(1):2. PubMed ID: 38227084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.
    Forlenza OV; Aprahamian I; Radanovic M; Talib LL; Camargo MZ; Stella F; Machado-Vieira R; Gattaz WF
    Bipolar Disord; 2016 Feb; 18(1):63-70. PubMed ID: 26876913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders.
    Nilsson J; Constantinescu J; Nellgård B; Jakobsson P; Brum WS; Gobom J; Forsgren L; Dalla K; Constantinescu R; Zetterberg H; Hansson O; Blennow K; Bäckström D; Brinkmalm A
    Mov Disord; 2023 Feb; 38(2):267-277. PubMed ID: 36504237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF.
    Boiten WA; van Steenoven I; Xiao MF; Worley PF; Noli B; Cocco C; Ferri GL; Lemstra AW; Teunissen CE
    Cells; 2020 Dec; 10(1):. PubMed ID: 33383752
    [No Abstract]   [Full Text] [Related]  

  • 9. Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: A systematic review.
    Knorr U; Simonsen AH; Zetterberg H; Blennow K; Hasselbalch SG; Kessing LV
    Eur Neuropsychopharmacol; 2018 Jul; 28(7):783-794. PubMed ID: 29802040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid erythropoietin, oxidative stress, and cognitive functions in patients with bipolar disorder and healthy control participants: A longitudinal case-control study.
    Miskowiak KW; Simonsen AH; Meyer M; Poulsen HE; Wilkan M; Forman J; Hasselbalch SG; Kessing LV; Knorr U
    J Psychiatr Res; 2023 Jul; 163():240-246. PubMed ID: 37244061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease.
    Libiger O; Shaw LM; Watson MH; Nairn AC; Umaña KL; Biarnes MC; Canet-Avilés RM; Jack CR; Breton YA; Cortes L; Chelsky D; Spellman DS; Baker SA; Raghavan N; Potter WZ; ;
    Alzheimers Dement; 2021 Dec; 17(12):1976-1987. PubMed ID: 33984181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the trajectory of bipolar disorder on global cognitive function: A one-year clinical prospective case-control study.
    Knorr U; Miskowiak K; Akhøj M; Vinberg M; Forman J; Kessing LV
    J Affect Disord; 2021 Jan; 278():189-198. PubMed ID: 32961415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome.
    Belbin O; Xiao MF; Xu D; Carmona-Iragui M; Pegueroles J; Benejam B; Videla L; Fernández S; Barroeta I; Nuñez-Llaves R; Montal V; Vilaplana E; Altuna M; Clarimón J; Alcolea D; Blesa R; Lleó A; Worley PF; Fortea J
    Mol Neurodegener; 2020 Aug; 15(1):46. PubMed ID: 32807227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.
    Wang H; Stewart T; Toledo JB; Ginghina C; Tang L; Atik A; Aro P; Shaw LM; Trojanowski JQ; Galasko DR; Edland S; Jensen PH; Shi M; Zhang J;
    J Alzheimers Dis; 2018; 61(4):1541-1553. PubMed ID: 29376878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia.
    van der Ende EL; Xiao M; Xu D; Poos JM; Panman JL; Jiskoot LC; Meeter LH; Dopper EG; Papma JM; Heller C; Convery R; Moore K; Bocchetta M; Neason M; Peakman G; Cash DM; Teunissen CE; Graff C; Synofzik M; Moreno F; Finger E; Sánchez-Valle R; Vandenberghe R; Laforce R; Masellis M; Tartaglia MC; Rowe JB; Butler CR; Ducharme S; Gerhard A; Danek A; Levin J; Pijnenburg YA; Otto M; Borroni B; Tagliavini F; de Mendonca A; Santana I; Galimberti D; Seelaar H; Rohrer JD; Worley PF; van Swieten JC;
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):612-621. PubMed ID: 32273328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.
    Saunders EF; Reider A; Singh G; Gelenberg AJ; Rapoport SI
    Bipolar Disord; 2015 Nov; 17(7):729-42. PubMed ID: 26424416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease.
    Massa F; Martinuzzo C; Gómez de San José N; Pelagotti V; Kreshpa W; Abu-Rumeileh S; Barba L; Mattioli P; Orso B; Brugnolo A; Girtler N; Vigo T; Arnaldi D; Serrati C; Uccelli A; Morbelli S; Chincarini A; Otto M; Pardini M
    J Neurol; 2024 Apr; 271(4):1999-2009. PubMed ID: 38157030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients.
    Jakobsson J; Bjerke M; Ekman CJ; Sellgren C; Johansson AG; Zetterberg H; Blennow K; Landén M
    Neuropsychopharmacology; 2014 Sep; 39(10):2349-56. PubMed ID: 24694925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Trajectory of Cerebrospinal Fluid Growth-Associated Protein 43 in the Alzheimer's Disease Continuum: A Longitudinal Study.
    Zhang H; Lyu D; Jia J;
    J Alzheimers Dis; 2022; 85(4):1441-1452. PubMed ID: 34958042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes.
    Isgren A; Sellgren C; Ekman CJ; Holmén-Larsson J; Blennow K; Zetterberg H; Jakobsson J; Landén M
    Brain Behav Immun; 2017 Oct; 65():195-201. PubMed ID: 28483660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.